TKIs or Chemoimmunotherapy for Frontline CLL Management?

Clinicians and patients now have several options for frontline management of chronic lymphocytic leukemia; exactly which option is preferred remains up for debate.

Source: CancerNetwork - October 3, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Hematologic Malignancies Leukemia & Lymphoma Conferences/NCCN 2016 Source Type: news